Germline and somatic genetics of osteosarcoma — connecting aetiology, biology and therapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Germline and somatic genetics of osteosarcoma — connecting aetiology, biology and therapy
Authors
Keywords
-
Journal
Nature Reviews Endocrinology
Volume 13, Issue 8, Pages 480-491
Publisher
Springer Nature
Online
2017-03-24
DOI
10.1038/nrendo.2017.16
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risks of first and subsequent cancers amongTP53mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort
- (2016) Phuong L. Mai et al. CANCER
- Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility
- (2016) Sarah K. Denny et al. CELL
- The role of pharmacogenetics in the treatment of osteosarcoma
- (2016) Hanneke I. Vos et al. DRUG DISCOVERY TODAY
- Notch Signaling and the Skeleton
- (2016) Stefano Zanotti et al. ENDOCRINE REVIEWS
- Exponentially growing osteosarcoma of mandible with acromegaly
- (2016) Nayeon Choi et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Evaluation of intraarterial and intravenous cisplatin chemotherapy in the treatment of metastatic osteosarcoma using an orthotopic xenograft mouse model
- (2016) Bernhard Robl et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Monogenic and polygenic determinants of sarcoma risk: an international genetic study
- (2016) Mandy L Ballinger et al. LANCET ONCOLOGY
- Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
- (2016) Neyssa M Marina et al. LANCET ONCOLOGY
- Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: An Evolving Paradigm of Molecularly Targeted Therapy
- (2016) Mohamed A. M. Ali Molecular Diagnosis & Therapy
- Prevalence of Metastasis at Diagnosis of Osteosarcoma: An International Comparison
- (2016) Tracy A. Marko et al. PEDIATRIC BLOOD & CANCER
- Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133-A Report From the Children's Oncology Group Bone Tumor Committee
- (2016) Michael W. Bishop et al. PEDIATRIC BLOOD & CANCER
- The pharmacogenomics of osteosarcoma
- (2016) M Serra et al. PHARMACOGENOMICS JOURNAL
- The clinical significance of changes in ezrin expression in osteosarcoma of children and young adults
- (2016) Iwona Lugowska et al. TUMOR BIOLOGY
- Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients
- (2016) Ekaterina A. Semenova et al. Cell Reports
- Analysis of Prognostic Factors in High-Grade Osteosarcoma of the Extremities in Children: A 15-Year Single-Institution Experience
- (2016) Liliana Vasquez et al. Frontiers in Oncology
- Dual mTORC1/2 inhibition by INK-128 results in antitumor activity in preclinical models of osteosarcoma
- (2015) Haibin Jiang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Bone cancer incidence by morphological subtype: a global assessment
- (2015) Patricia C. Valery et al. CANCER CAUSES & CONTROL
- Prognostic factors for survival in patients with high-grade osteosarcoma using the Surveillance, Epidemiology, and End Results (SEER) Program database
- (2015) Kyle R. Duchman et al. Cancer Epidemiology
- Role of pharmacogenetics of drug-metabolizing enzymes in treating osteosarcoma
- (2015) Claudia Maria Hattinger et al. Expert Opinion on Drug Metabolism & Toxicology
- Infant birthweight and risk of childhood cancer: international population-based case control studies of 40 000 cases
- (2015) Kate A O’Neill et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
- (2015) Stefan S. Bielack et al. JOURNAL OF CLINICAL ONCOLOGY
- Germline TP53 Variants and Susceptibility to Osteosarcoma
- (2015) Lisa Mirabello et al. JNCI-Journal of the National Cancer Institute
- Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial
- (2015) Giovanni Grignani et al. LANCET ONCOLOGY
- RUNX2 and the PI3K/AKT axis reciprocal activation as a driving force for tumor progression
- (2015) Karine A. Cohen-Solal et al. Molecular Cancer
- A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis
- (2015) Branden S Moriarity et al. NATURE GENETICS
- Germline Mutations in Predisposition Genes in Pediatric Cancer
- (2015) Jinghui Zhang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma
- (2015) Haibin Zeng et al. PATHOLOGY & ONCOLOGY RESEARCH
- Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency
- (2015) Michal Kovac et al. Nature Communications
- A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma
- (2015) L. Mirabello et al. Cancer Discovery
- High Birth Weight Increases the Risk for Bone Tumor: A Systematic Review and Meta-Analysis
- (2015) Songfeng Chen et al. International Journal of Environmental Research and Public Health
- Germline TP53 Variants and Susceptibility to Osteosarcoma
- (2015) Lisa Mirabello et al. JNCI-Journal of the National Cancer Institute
- EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment†
- (2014) J. S. Whelan et al. ANNALS OF ONCOLOGY
- Whole-exome sequencing and functional studies identify RPS29 as a novel gene mutated in multicase Diamond-Blackfan anemia families
- (2014) L. Mirabello et al. BLOOD
- Notch Activation as a Driver of Osteogenic Sarcoma
- (2014) Jianning Tao et al. CANCER CELL
- Combination of the mTOR Inhibitor Ridaforolimus and the Anti-IGF1R Monoclonal Antibody Dalotuzumab: Preclinical Characterization and Phase I Clinical Trial
- (2014) S. Di Cosimo et al. CLINICAL CANCER RESEARCH
- Risk of Subsequent Malignant Neoplasms in Long-Term Hereditary Retinoblastoma Survivors After Chemotherapy and Radiotherapy
- (2014) Jeannette R. Wong et al. JOURNAL OF CLINICAL ONCOLOGY
- GRM4 gene polymorphism is associated with susceptibility and prognosis of osteosarcoma in a Chinese Han population
- (2014) Chaoyin Jiang et al. MEDICAL ONCOLOGY
- Association of the Polymorphisms in the Fas/FasL Promoter Regions with Cancer Susceptibility: A Systematic Review and Meta-Analysis of 52 Studies
- (2014) Yeqiong Xu et al. PLoS One
- Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma
- (2014) Jennifer A. Perry et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma
- (2014) Xiang Chen et al. Cell Reports
- Inhibition of the Wnt-β-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy
- (2013) Yimin Ma et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Correlation of WWOX, RUNX2 and VEGFA protein expression in human osteosarcoma
- (2013) Jilong Yang et al. BMC Medical Genomics
- HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors
- (2013) Deanna D Dailey et al. BMC Veterinary Research
- Association analysis between genetic variants of MDM2 gene and osteosarcoma susceptibility in Chinese
- (2013) Jinshan He et al. ENDOCRINE JOURNAL
- Wnt Pathway in Osteosarcoma, from Oncogenic to Therapeutic
- (2013) Yu Cai et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Association of ITGA3 gene polymorphisms with susceptibility and clinicopathological characteristics of osteosarcoma
- (2013) Wu Yang et al. MEDICAL ONCOLOGY
- Genome-wide association study identifies two susceptibility loci for osteosarcoma
- (2013) Sharon A Savage et al. NATURE GENETICS
- The Prognostic Role of Ezrin Immunoexpression in Osteosarcoma: A Meta-Analysis of Published Data
- (2013) Hongtao Li et al. PLoS One
- The prognostic value of elevated ezrin in patients with osteosarcoma
- (2013) Deng-Xing Lun et al. TUMOR BIOLOGY
- Association of RECQL5 gene polymorphisms and osteosarcoma in a Chinese Han population
- (2013) Li-Qiang Zhi et al. TUMOR BIOLOGY
- Association of the vascular endothelial growth factor (VEGF) gene single-nucleotide polymorphisms with osteosarcoma susceptibility in a Chinese population
- (2013) Zhen Wang et al. TUMOR BIOLOGY
- Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis
- (2013) Xiao-Wei Yu et al. TUMOR BIOLOGY
- Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage
- (2013) T Ozaki et al. Cell Death & Disease
- Notch Signaling is Associated with ALDH Activity and an Aggressive Metastatic Phenotype in Murine Osteosarcoma Cells
- (2013) Xiaodong Mu et al. Frontiers in Oncology
- Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry
- (2012) A. Vlachos et al. BLOOD
- Association of FGFR3 and MDM2 Gene Nucleotide Polymorphisms with Bone Tumors
- (2012) V. A. Naumov et al. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
- Patterns of Bone Sarcomas as a Second Malignancy in Relation to Radiotherapy in Adulthood and Histologic Type
- (2012) L. C. Wu et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- Lysyl Oxidase Polymorphisms and Susceptibility to Osteosarcoma
- (2012) Yang Liu et al. PLoS One
- A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma
- (2011) Lisa Mirabello et al. BMC CANCER
- High-throughput genotyping in osteosarcoma identifies multiple mutations in phosphoinositide-3-kinase and other oncogenes
- (2011) Edwin Choy et al. CANCER
- Height at diagnosis and birth-weight as risk factors for osteosarcoma
- (2011) Lisa Mirabello et al. CANCER CAUSES & CONTROL
- Relationship between height at diagnosis and bone tumours in young people: a meta-analysis
- (2011) Ramandeep S. Arora et al. CANCER CAUSES & CONTROL
- Age-Period-Cohort Analysis of Primary Bone Cancer Incidence Rates in the United States (1976-2005)
- (2011) K. P. Anfinsen et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- miR-20a Encoded by the miR-17-92 Cluster Increases the Metastatic Potential of Osteosarcoma Cells by Regulating Fas Expression
- (2011) G. Huang et al. CANCER RESEARCH
- Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development
- (2011) Philip J. Stephens et al. CELL
- Cytotoxic T-lymphocyte Antigen-4 Polymorphisms and Susceptibility to Osteosarcoma
- (2011) Yang Liu et al. DNA AND CELL BIOLOGY
- CD86 + 1057G/A Polymorphism and Susceptibility to Osteosarcoma
- (2011) Wen Wang et al. DNA AND CELL BIOLOGY
- Cytotoxic T-Lymphocyte Antigen-4 +49G/A Polymorphism Is Associated with Increased Risk of Osteosarcoma
- (2011) Wen Wang et al. Genetic Testing and Molecular Biomarkers
- Wnt10b activates the wnt, notch, and NFκB pathways in u2os osteosarcoma cells
- (2011) Ulrike I. Mödder et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Phase II Study of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus in Patients With Advanced Bone and Soft Tissue Sarcomas
- (2011) Sant P. Chawla et al. JOURNAL OF CLINICAL ONCOLOGY
- Initial testing (stage 1) by the pediatric preclinical testing program of RO4929097, a γ-secretase inhibitor targeting notch signaling
- (2011) E. Anders Kolb et al. PEDIATRIC BLOOD & CANCER
- Dog models of naturally occurring cancer
- (2011) Jennie L. Rowell et al. TRENDS IN MOLECULAR MEDICINE
- Association between TGFBR1*6A and osteosarcoma: A Chinese case-control study
- (2010) Yun-Sheng Hu et al. BMC CANCER
- Genetic variation at chromosome 8q24 in osteosarcoma cases and controls
- (2010) L. Mirabello et al. CARCINOGENESIS
- The ribosomal basis of diamond-blackfan anemia: mutation and database update
- (2010) Ilenia Boria et al. HUMAN MUTATION
- Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects
- (2010) Katherine A Janeway et al. LANCET ONCOLOGY
- Int7G24A variant of transforming growth factor-beta receptor 1 is associated with osteosarcoma susceptibility in a Chinese population
- (2010) Yun-Sheng Hu et al. MEDICAL ONCOLOGY
- Organizing the cell cortex: the role of ERM proteins
- (2010) Richard G. Fehon et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- mTOR: from growth signal integration to cancer, diabetes and ageing
- (2010) Roberto Zoncu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Glutathione S-transferase polymorphisms in osteosarcoma patients
- (2010) Carolina Salinas-Souza et al. Pharmacogenetics and Genomics
- Inhibition of Notch pathway prevents osteosarcoma growth by cell cycle regulation
- (2009) M Tanaka et al. BRITISH JOURNAL OF CANCER
- Osteosarcoma incidence and survival rates from 1973 to 2004
- (2009) Lisa Mirabello et al. CANCER
- Effect of TP53 Arg72Pro and MDM2 SNP309 Polymorphisms on the Risk of High-Grade Osteosarcoma Development and Survival
- (2009) G. Toffoli et al. CLINICAL CANCER RESEARCH
- Identification of interactive networks of gene expression associated with osteosarcoma oncogenesis by integrated molecular profiling
- (2009) Bekim Sadikovic et al. HUMAN MOLECULAR GENETICS
- Notch signaling contributes to the pathogenesis of human osteosarcomas
- (2009) F. Engin et al. HUMAN MOLECULAR GENETICS
- International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons
- (2009) Lisa Mirabello et al. INTERNATIONAL JOURNAL OF CANCER
- 2009 Version of the Chompret Criteria for Li Fraumeni Syndrome
- (2009) Julie Tinat et al. JOURNAL OF CLINICAL ONCOLOGY
- Cause-Specific Mortality in Long-Term Survivors of Retinoblastoma
- (2009) C.-L. Yu et al. JNCI-Journal of the National Cancer Institute
- mTOR/p70S6K Signal transduction pathway contributes to osteosarcoma progression and patients’ prognosis
- (2009) Quan Zhou et al. MEDICAL ONCOLOGY
- Launching a Novel Preclinical Infrastructure: Comparative Oncology Trials Consortium Directed Therapeutic Targeting of TNFα to Cancer Vasculature
- (2009) Melissa C. Paoloni et al. PLoS One
- Alterations of the Notch pathway in lung cancer
- (2009) Britta Westhoff et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Copy number gains inEGFRand copy number losses inPTENare common events in osteosarcoma tumors
- (2008) Serena S. Freeman et al. CANCER
- The mutation spectrum in RECQL4 diseases
- (2008) H Annika Siitonen et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer
- (2008) Adam Elzagheid et al. HUMAN PATHOLOGY
- Phase I Trial of the Novel Mammalian Target of Rapamycin Inhibitor Deforolimus (AP23573; MK-8669) Administered Intravenously Daily for 5 Days Every 2 Weeks to Patients With Advanced Malignancies
- (2008) Monica M. Mita et al. JOURNAL OF CLINICAL ONCOLOGY
- The Osterix Transcription Factor Down-Regulates Interleukin-1 Expression in Mouse Osteosarcoma Cells
- (2008) Y. Cao et al. MOLECULAR CANCER RESEARCH
- Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation
- (2008) Matthew J Hilton et al. NATURE MEDICINE
- Trends in childhood cancer incidence in the U.S. (1992–2004)
- (2007) Amy M. Linabery et al. CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now